Work

Faculty Opinions recommendation of Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study.

Cites:
Cited by:
Related to: 10